Back to Authors

Brunton, Amanda E.

https://orcid.org/0000-0003-4061-5870

A5060498946 | I4210133259

Mayo Clinic

Bronchiectasis and NTM Association , Miami, FL,

Citations 16

Characteristics of Bronchiectasis Patients Who Tested Positive for Coronavirus Disease 2019 - Data From the United States Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease Research Registry

B28. SOLVING THE PUZZLE OF BRONCHIECTASIS AND NONTUBERCULOUS MYCOBACTERIA | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A2956-A2956

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a2956

Clinical Features of Patients With an Eosinophilic Phenotype: An Analysis of the U.S Bronchiectasis and NTM Research Registry

B103. HOT TOPICS IN CYSTIC FIBROSIS, BRONCHIECTASIS, AND BREATHLESSNESS | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A4310-A4310

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4310

Cftr Mutation and Increased Rates of Pulmonary Infections Among Patients From the US Bronchiectasis and NTM Research Registry

B98. THE HAPPY COUPLE: BRONCHIECTASIS AND NONTUBERCULOUS MYCOBACTERIA | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A4244-A4244

10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a4244

Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines

Clinical Infectious Diseases | September 22, 2022 | Volume: 76 | Issue: 2 | Pages: 338-341

10.1093/cid/ciac788 | PMID 36134755

Abstract Among 1038 participants with pulmonary Mycobacterium avium complex and 120 with Mycobacterium abscessus enrolled in the US Bronchiectasis and NTM Research Registry, less than half received antibiotic therapy in the 24 months before registry enrollment, of which less than half were guideline based. Adverse effects occurred in 21% of therapy recipients, of whom 33% discontinued therapy.
Isolation of Pseudomonas aeruginosa after nontuberculous mycobacteria

The International Journal of Tuberculosis and Lung Disease | May 4, 2022 | Volume: 26 | Issue: 5 | Pages: 460-462

10.5588/ijtld.21.0572 | PMID 35505473

Self-Reported Symptom and Adverse Event Profiles in Macrolide-Based Oral Treatment of Mycobacterium Avium Complex Pulmonary Disease

C28. LET'S TALK NTM | May 2, 2022 | Volume: No volume available | Issue: No issue available | Pages: A3882-A3882

10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3882